|
WO2021076906A1
|
|
Tlr7/8 agonists to enhance immune responses in opioid using individuals
|
|
WO2021072034A1
|
|
Methods and compositions for treating ataxia telangiectasia
|
|
WO2021067629A1
|
|
Microglia specific promoters and methods of use therefore
|
|
WO2021067611A2
|
|
Compositions and methods for treating alzheimer's disease
|
|
WO2021067613A1
|
|
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2021055580A2
|
|
An anaplastic lymphoma kinase (alk) cancer vaccine and methods of use
|
|
WO2021055386A1
|
|
Use of thiazole amide compounds for modulating human immune response
|
|
US2021069216A1
|
|
Compositions and methods of treating neuronal injury
|
|
US2021059220A1
|
|
Test environment for the characterization of neuropathic pain
|
|
WO2021041171A1
|
|
Intercellular adhesion molecule 1 (icam1) antibody drug conjugate and uses thereof
|
|
WO2021034582A1
|
|
Large scale production of exosome mimetics and uses thereof
|
|
WO2021026294A1
|
|
Methods and compositions for reconstituting microglia
|
|
WO2021021735A1
|
|
Methods and compositions for characterizing inflammatory bowel disease
|
|
WO2021003330A1
|
|
Inhibiting the rna methyltransferase mettl3 or its interaction with eif3h to suppress oncogene translation and tumorigenesis
|
|
WO2021003337A1
|
|
Compositions and methods for gene replacement
|
|
WO2020257514A1
|
|
Methods and compositions for allele specific gene editing
|
|
US2020385685A1
|
|
Robust differentiation of human pluripotent stem cells into endothelial cells using transcription factor etv2
|
|
WO2020227682A1
|
|
Treating cancer
|
|
WO2020219895A1
|
|
Abcb5+ stem cell therapeutics for liver disease
|
|
WO2020219803A1
|
|
Reconstruction augmentation by constraining with intensity gradients in mri
|
